CBmed is offering customer-tailored contract research within CBsolutions. In cooperation with our partners we are providing a wide variety of services. Starting with the definition of specific research questions, our team can set up clinical trials from study design to execution until completion.

Our Public-Privat-Partnership Model for tailored biomarker solutions.

Linking our cutting-edge Core Technologies together with specialized services of our widespread scientific partner network, we are capable of handling projects with a very high degree of complexity. Standardized workflows guarantee reproducible results. Highest quality standards from sample acquisition until delivery of lab results are utmost importance for us. Beyond on demand-services we additionally provide joint approaches to 3rd party funding within Europe and abroad, together with experienced consortium partners from academia and industry.

Retrospective & Prospective Clinical cohorts

Biobanks

Vienna General Hospital

In the top 10 largest hospitals in EU
> 450 specialized outpatient units
~ 2,000 beds
~ 114,000 inpatients/year
~ 1,773,000 outpatients/year

Styria region including Graz

Network of 23 hospital sites in Styria including
University Clinic Graz
~ 5,800 beds
~ 250,000 inpatients/year
~ 950,000 outpatients/year

BBMRI-ERIC and BioBank Graz

European Biobank Consortium with HQ in Graz
515 biobanks with
> 60 million biospecimens
> 7 million directly in Graz


Selected Projects

  • Flow cytometry analysis of the InterFAST cohort
  • Method establishment and mutation analysis in colon carcinoma
  • Biomarker research based on a retrospective clinical study with candidate expression confirmation in ovarian carcinoma using digital pathology
  • Biomarker research based on a prospective clinical study with candidate expression confirmation and analysis in clear cell renal cell carcinoma using digital pathology
  • Study design for RNA sequencing for head and neck cancer
  • FACS analysis for the impact of hypoglycaemia in patients with DIAbetes mellitus type 2 on PLATElet activation (DIAPLATE) study
  • Treg subtype FACS analysis in the peripheral blood of kidney transplant recipients
  • Application of an MS-platform in pulmonary hypertension disease

 

CBmed GmbH Center for Biomarker Research in Medicine
Stiftingtalstrasse 5   8010 Graz   Austria   office@cbmed.at   +43 316 385 28801